Online citations, reference lists, and bibliographies.
← Back to Search

Oligonucleotide Aptamers: Emerging Affinity Probes For Bioanalytical Mass Spectrometry And Biomarker Discovery

Basri Gulbakan
Published 2015 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Selective isolation of biologically important molecules and their functional characterization is one of the primary goals of bioanalytical chemistry. Several different affinity tools such as antibodies, affimers, nanobodies, and DARPins have been explored to achieve these goals. In recent years, oligonucleotide based affinity tools called aptamers have become progressively attractive and the research in this area has seen an exponential increase. Aptamer probes have been explored in many different areas of bioanalytical chemistry such as electrochemical and optical biosensor development, targeted drug delivery, logic gates, DNA nanotechnology, and point of care diagnostics. However aptamers are still largely overlooked in mass spectrometry (MS) and biomarker discovery. After the completion of the human genome project, the focus has shifted towards functional genomics and to understand the living systems by deciphering the functions of proteins and metabolites. Therefore identification and functional characterization of these molecules are of outmost importance. Although identification of isolated biomolecules and analysis of simple biological mixtures using MS have become relatively simple, the power of MS gradually decreases as the complexity of biological mixtures increases. Therefore the development of selective and targeted approaches is at the forefront of mass spectrometry. Aptamers have great potential in affinity mass spectrometry to improve selectivity, specificity and throughput. Herein, bioanalytical mass spectrometry and biomarker discovery applications of aptamers will be reviewed.
This paper references
10.2217/fmb.12.149
Antimicrobial aptamers for detection and inhibition of microbial pathogen growth.
V. C. Özalp (2013)
10.1371/journal.pone.0061002
Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment
M. A. De Groote (2013)
10.1039/C4RA12407C
Targeting cancer cells using aptamers: cell-SELEX approach and recent advancements
J. Barman (2015)
10.1126/SCIENCE.2200121
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.
C. Tuerk (1990)
10.1371/journal.pone.0035157
Protein Signature of Lung Cancer Tissues
Michael R. Mehan (2012)
10.1021/ac501488b
Aptamer/ISET-MS: a new affinity-based MALDI technique for improved detection of biomarkers.
S. Lee (2014)
10.2116/ANALSCI.26.1229
Functionalized nanoparticles and nanostructured surfaces for surface-assisted laser desorption/ionization mass spectrometry.
R. Arakawa (2010)
10.1074/jbc.M112.348904
The Cytosolic Domain of Protein-tyrosine Kinase 7 (PTK7), Generated from Sequential Cleavage by a Disintegrin and Metalloprotease 17 (ADAM17) and γ-Secretase, Enhances Cell Proliferation and Migration in Colon Cancer Cells*
Hye-Won Na (2012)
10.1021/pr900265r
Kinetic binding analysis of aptamers targeting HIV-1 proteins by a combination of a microbalance array and mass spectrometry (MAMS).
T. Gronewold (2009)
10.1021/AC060606R
Structural features of the L-argininamide-binding DNA aptamer studied with ESI-FTMS.
X. Guo (2006)
10.1016/j.jasms.2008.03.003
Strong anion exchange for studying protein—dna interactions by H/D exchange mass spectrometry
J. Sperry (2008)
10.1158/0008-5472.CAN-12-3682
Alkaline phosphatase ALPPL-2 is a novel pancreatic carcinoma-associated protein.
Pooja Dua (2013)
10.1128/EC.2.1.84-94.2003
Targeting the Variable Surface of African Trypanosomes with Variant Surface Glycoprotein-Specific, Serum-Stable RNA Aptamers
Mihaela Lorger (2003)
10.1021/AC070023X
Analysis of adenosine triphosphate and glutathione through gold nanoparticles assisted laser desorption/ionization mass spectrometry.
Y. Huang (2007)
10.1039/c4mb00729h
Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism.
Emanuela Scolamiero (2015)
10.1371/journal.pone.0015004
Aptamer-based multiplexed proteomic technology for biomarker discovery
L. Gold (2010)
10.1371/journal.pone.0084472
PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement
Silvia Gärtner (2014)
10.1039/c0lc00211a
High-density micro-arrays for mass spectrometry.
P. Urban (2010)
10.1021/AC061154L
Small-molecule analysis with silicon-nanoparticle-assisted laser desorption/ionization mass spectrometry.
Xiujuan Wen (2007)
10.1016/j.bios.2013.06.060
Site-directed antibody immobilization techniques for immunosensors.
A. Makaraviciute (2013)
10.1038/cr.2015.7
Characterization and target identification of a DNA aptamer that labels pluripotent stem cells
Zhonggang Hou (2015)
10.1038/sdata.2014.31
A repository of assays to quantify 10,000 human proteins by SWATH-MS
G. Rosenberger (2014)
10.1039/c3an01619f
Protein microarray technology: how far off is routine diagnostics?
M. Cretich (2014)
10.1021/PR060062+
Multiplexed mass spectrometric immunoassay in biomarker research: a novel approach to the determination of a myocardial infarct.
U. Kiernan (2006)
10.1158/0008-5472.CAN-13-2775
A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma.
R. Chen (2014)
10.1038/nprot.2010.66
Development of DNA aptamers using Cell-SELEX
K. Sefah (2010)
10.1021/ja801951p
Aptamer-facilitated biomarker discovery (AptaBiD).
M. Berezovski (2008)
10.1093/NAR/GKH862
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.
K. Schmidt (2004)
10.1371/journal.pone.0046091
Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
R. Ostroff (2012)
10.1073/PNAS.95.6.2902
High affinity ligands from in vitro selection: complex targets.
K. Morris (1998)
10.1002/cbic.201100774
Kinetic and Stoichiometric Characterisation of Streptavidin‐Binding Aptamers
Vincent J. B. Ruigrok (2012)
10.1002/anie.200804643
The chemical biology of aptamers.
G. Mayer (2009)
10.1002/anie.201300566
Development of a MALDI-TOF MS strategy for the high-throughput analysis of biomarkers: on-target aptamer immobilization and laser-accelerated proteolysis.
Xueyang Zhang (2013)
10.1021/bc4002823
Protein engineering for directed immobilization.
E. Steen Redeker (2013)
10.1002/ELPS.200406103
Microbead‐based affinity chromatography chip using RNA aptamer modified with photocleavable linker
S. Cho (2004)
10.1021/ac101801j
Aptamers recognizing glycosylated hemagglutinin expressed on the surface of vaccinia virus-infected cells.
Parag Anil Parekh (2010)
10.1038/nrd1955
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Eugene W. M. Ng (2006)
10.2217/bmm.09.5
Aptamers generated by Cell SELEX for biomarker discovery.
Youngmi Kim (2009)
10.1021/ja109042w
A dual platform for selective analyte enrichment and ionization in mass spectrometry using aptamer-conjugated graphene oxide.
Basri Gulbakan (2010)
10.1021/cb400619v
Dissecting the effect of RNA aptamer binding on the dynamics of plasminogen activator inhibitor 1 using hydrogen/deuterium exchange mass spectrometry.
M. B. Trelle (2014)
10.1038/20400
Desorption–ionization mass spectrometry on porous silicon
Jing Wei (1999)
10.1039/c1an15605e
Modern analytical techniques in metabolomics analysis.
A. Zhang (2012)
10.1021/ac500466x
Identification of Cell Membrane Protein Stress-Induced Phosphoprotein 1 as a Potential Ovarian Cancer Biomarker Using Aptamers Selected by Cell Systematic Evolution of Ligands by Exponential Enrichment
Dimitri Van Simaeys (2014)
10.1021/AC049860E
Aptamer-enhanced laser desorption/ionization for affinity mass spectrometry.
Lawrence W. Dick (2004)
10.1021/AC701982E
Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics.
A. Nordström (2008)
10.1021/nn304458m
Aptamer-conjugated multifunctional nanoflowers as a platform for targeting, capture, and detection in laser desorption ionization mass spectrometry.
I. Ocsoy (2013)
10.1039/C3SC51410B
Direct access to aptamer–protein complexes via MALDI-MS
F. Chen (2013)
10.1016/j.jpba.2013.03.014
Nucleic acid aptamers as high affinity ligands in biotechnology and biosensorics.
T. Smuc (2013)
10.1002/ANIE.200300605
Electrospray wings for molecular elephants (Nobel lecture).
J. Fenn (2003)
10.1074/mcp.O111.016717
Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis*
L. Gillet (2012)
10.1146/annurev-anchem-071213-015944
Nucleic acid aptamers for living cell analysis.
Xiangling Xiong (2014)
10.1182/blood-2010-01-262352
The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome.
T. Prebet (2010)
10.1074/JBC.M104651200
Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein*
B. Hicke (2001)
10.1039/c2cs15331a
Mass spectrometry-based proteomics: existing capabilities and future directions.
T. E. Angel (2012)
10.1021/ac302217u
Aptamer-based impedimetric sensor for bacterial typing.
Mahmoud Labib (2012)
10.1074/mcp.M114.038273
Glycoproteomic Analysis of Prostate Cancer Tissues by SWATH Mass Spectrometry Discovers N-acylethanolamine Acid Amidase and Protein Tyrosine Kinase 7 as Signatures for Tumor Aggressiveness*
Y. Liu (2014)
10.1016/J.BBRC.2007.04.007
Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis.
F. Chen (2007)
10.1021/AC049657J
High sensitivity and analyte capture with desorption/ionization mass spectrometry on silylated porous silicon.
S. Trauger (2004)
10.1016/j.tibtech.2012.11.010
Nanoproteomics: a new sprout from emerging links between nanotechnology and proteomics.
Lee Jia (2013)
10.1016/j.jasms.2010.03.035
Mass spectrometric studies of alkali metal ion binding on thrombin-binding aptamer DNA
Eun Sun Hong (2010)
10.1371/journal.pone.0015003
Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer
R. Ostroff (2010)
10.1074/mcp.M700026-MCP200
Aptamer Directly Evolved from Live Cells Recognizes Membrane Bound Immunoglobin Heavy Mu Chain in Burkitt's Lymphoma Cells*S
Prabodhika Mallikaratchy (2007)
10.1021/pr700894d
Cell-specific aptamer probes for membrane protein elucidation in cancer cells.
Dihua Shangguan (2008)
10.1373/clinchem.2014.225771
Newborn screening for lysosomal storage diseases.
M. Gelb (2015)
10.1016/j.aca.2008.05.031
Applications of aptamers in cancer cell biology.
J. Phillips (2008)
10.1021/ac5040242
Applications of Hydrogen/Deuterium Exchange MS from 2012 to 2014
Gregory F. Pirrone (2015)
10.1021/AC060405N
Adjustable fragmentation in laser desorption/ionization from laser-induced silicon microcolumn arrays.
Y. Chen (2006)
10.1021/pr100300t
Aptamer microarray mediated capture and mass spectrometry identification of biomarker in serum samples.
J. Ahn (2010)
10.1073/pnas.1311778111
In vitro selection with artificial expanded genetic information systems
K. Sefah (2013)
10.1038/nmeth.1333
A HUPO test sample study reveals common problems in mass spectrometry-based proteomics
A. Bell (2009)
10.1016/j.leukres.2012.07.004
PTK7: a new biomarker for immunophenotypic characterization of maturing T cells and T cell acute lymphoblastic leukemia.
Guohua Jiang (2012)
10.1006/ABIO.2002.5710
Binding stoichiometry of an RNA aptamer and its transcription factor target.
L. A. Cassiday (2002)
10.1021/ac101149b
Laser desorption ionization mass spectrometry on silicon nanowell arrays.
Basri Gulbakan (2010)
10.3233/JAD-130380
Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study.
S. Kiddle (2014)
10.1021/JA056097C
Insulin capture by an insulin-linked polymorphic region G-quadruplex DNA oligonucleotide.
Adam C Connor (2006)
10.1002/RCM.1634
Functionalized nanoparticles for liquid atmospheric pressure matrix-assisted laser desorption/ionization peptide analysis.
Kevin Turney (2004)
10.1038/nrd3141
Aptamers as therapeutics
A. Keefe (2010)
10.1016/S0956-5663(99)00028-7
In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection.
J. Bruno (1999)
10.1021/AC00171A028
Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons.
M. Karas (1988)
10.1016/j.jprot.2013.10.012
The strategy, organization, and progress of the HUPO Human Proteome Project.
Gilbert S. Omenn (2014)
10.1002/JMS.915
Electrospray ionization of nucleic acid aptamer/small molecule complexes for screening aptamer selectivity.
K. Keller (2005)
10.1039/c0cs00050g
Nanoparticle-based mass spectrometry for the analysis of biomolecules.
Cheng-Kang Chiang (2011)
10.1016/j.bios.2008.01.013
Combination of a SAW-biosensor with MALDI mass spectrometric analysis.
G. Treitz (2008)
10.3390/ijms150711665
Protein Tyrosine Kinase 7 (PTK7) as a Predictor of Lymph Node Metastases and a Novel Prognostic Biomarker in Patients with Prostate Cancer
Hongtuan Zhang (2014)
10.1021/ac402669e
DNA oligonucleotides: a model system with tunable binding strength to study monomer-dimer equilibria with electrospray ionization-mass spectrometry.
K. Barylyuk (2013)
10.1038/mt.2012.163
Targeting Axl with an high-affinity inhibitory aptamer.
L. Cerchia (2012)
10.1093/CLINCHEM/48.10.1865
Photoaptamer Technology: Development of Multiplexed Microarray Protein Assays
D. Zichi (2002)
10.1016/J.BBRC.2006.06.132
Identification of proteins bound to a thioaptamer probe on a proteomics array.
H. Wang (2006)
10.1016/S0168-1656(02)00360-7
Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment.
C. Wang (2003)
10.1089/oli.2010.0264
Cell-specific aptamer-mediated targeted drug delivery.
J. Zhou (2011)
10.1002/cyto.a.20766
Disease‐specific biomarker discovery by aptamers
H. Ulrich (2009)
10.1039/c2cc17997k
An aptamer based on-plate microarray for high-throughput insulin detection by MALDI-TOF MS.
Xueyang Zhang (2012)
10.1002/cam4.260
Identification and expression of troponin T, a new marker on the surface of cultured tumor endothelial cells by aptamer ligand
M. N. Ara (2014)
10.1146/annurev-biochem-072909-100424
Mass spectrometry-based proteomics and network biology.
A. Bensimon (2012)
10.1073/pnas.0602615103
Aptamers evolved from live cells as effective molecular probes for cancer study
Dihua Shangguan (2006)
10.1021/ac901154s
Analysis of protein conformation and dynamics by hydrogen/deuterium exchange MS.
J. Engen (2009)
10.1038/nbt.2556
Generation of high-affinity DNA aptamers using an expanded genetic alphabet
M. Kimoto (2013)
10.3390/v7020751
Aptamers in Diagnostics and Treatment of Viral Infections
Tomasz Wandtke (2015)
10.1007/s13361-012-0498-4
Biomimetic Antireflective Silicon Nanocones Array for Small Molecules Analysis
Y. Wang (2012)
10.1002/PMIC.200300631
Photoaptamer arrays applied to multiplexed proteomic analysis
C. Bock (2004)
10.1021/ac5025649
Autonomous Metabolomics for Rapid Metabolite Identification in Global Profiling
H. P. Benton (2015)
10.1038/nature06916
Mining the plasma proteome for cancer biomarkers
S. Hanash (2008)
10.1016/j.chembiol.2014.08.003
Aptamers and SELEX in Chemistry & Biology.
M. Famulok (2014)
10.1038/nrmicro1458
Aptamers come of age – at last
D. Bunka (2006)
10.1016/j.jasms.2010.01.024
Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension
J. D. Reid (2010)
10.1093/NAR/27.9.2006
Combinatorial selection of high affinity RNA ligands to live African trypanosomes.
M. Homann (1999)
10.1002/anie.201204174
Aptamer-based affinity labeling of proteins.
Jan L. Vinkenborg (2012)
10.1039/B607833H
Biomarker discovery by proteomics: challenges not only for the analytical chemist.
P. Horvatovich (2006)
10.1371/journal.pone.0026332
From SOMAmer-Based Biomarker Discovery to Diagnostic and Clinical Applications: A SOMAmer-Based, Streamlined Multiplex Proteomic Assay
S. Krämer (2011)
10.1038/346818A0
In vitro selection of RNA molecules that bind specific ligands
A. Ellington (1990)
10.1021/ja908035g
Expanding the chemistry of DNA for in vitro selection.
Jonathan D. Vaught (2010)
10.1016/j.ajpath.2011.10.024
Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array.
G. Baird (2012)
10.1002/mas.21462
Applying mass spectrometry to study non-covalent biomolecule complexes.
F. Chen (2016)
10.1002/RCM.1290020802
Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry
K. Tanaka (1988)
10.1016/j.trac.2011.08.006
Selection and analytical applications of aptamers binding microbial pathogens
C. Hamula (2011)
10.1111/lam.12295
Specific capture and detection of Staphylococcus aureus with high-affinity modified aptamers to cell surface components
A. Baumstummler (2014)
10.1016/j.copbio.2014.08.003
Determination of thermodynamic and kinetic properties of biomolecules by mass spectrometry.
Basri Gülbakan (2015)
10.1074/JBC.M100347200
Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels
M. Blank (2001)
10.1021/ac300806s
Enrichment and detection of rare proteins with aptamer-conjugated gold nanorods.
Emir Yasun (2012)
10.1146/annurev.pharmtox.010909.105547
Discovery and development of therapeutic aptamers.
P. Bouchard (2010)
10.1089/omi.2013.0074
Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences.
F. Kobeissy (2014)
10.1038/nbt1235
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
N. Rifai (2006)
10.1021/AC061256B
Affinity capture and detection of immunoglobulin E in human serum using an aptamer-modified surface in matrix-assisted laser desorption/ionization mass spectrometry.
J. Cole (2007)
10.1016/j.talanta.2014.05.045
Development of aptamer-conjugated magnetic graphene/gold nanoparticle hybrid nanocomposites for specific enrichment and rapid analysis of thrombin by MALDI-TOF MS.
Ya Xiong (2014)
10.1039/c3an01577g
A critical comparison of protein microarray fabrication technologies.
V. Romanov (2014)
10.1016/j.bbapap.2013.10.016
Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins.
G. Omenn (2014)
10.1073/pnas.2136683100
A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment
D. Daniels (2003)
10.1074/jbc.M111859200
In Vitro Selection of RNA Aptamers That Bind to Cell Adhesion Receptors of Trypanosoma cruzi and Inhibit Cell Invasion*
H. Ulrich (2002)
10.1373/clinchem.2011.180596
Mass spectrometry in biomarker applications: from untargeted discovery to targeted verification, and implications for platform convergence and clinical application.
R. Smith (2012)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar